|
|
Volumn 44, Issue 3, 2009, Pages 186-197
|
|
Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives - An Introduction. Evidence-Based recommendations for the Risk-Benefit Analysis in Hemotherapy;Bluttransfusion Die neuen Querschnitts-Leitiinien der Bundesä rztekammer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD DONOR;
BLOOD TRANSFUSION;
HEALTH CARE;
HEALTH INSURANCE;
HUMAN;
LAW;
MEDICAL PRACTICE;
MEDICAL SERVICE;
PRACTICE GUIDELINE;
REVIEW;
ARTICLE;
BLOOD COMPONENT THERAPY;
EVIDENCE BASED MEDICINE;
HEALTH CARE QUALITY;
MEDICAL SOCIETY;
PHYSIOLOGY;
PLASMA;
RISK ASSESSMENT;
RISK FACTOR;
STANDARD;
BLOOD COMPONENT TRANSFUSION;
BLOOD TRANSFUSION;
EVIDENCE-BASED MEDICINE;
HUMANS;
PLASMA;
QUALITY ASSURANCE, HEALTH CARE;
RISK ASSESSMENT;
RISK FACTORS;
SOCIETIES, MEDICAL;
|
|
EID: 64549088992
PISSN: 09392661
EISSN: 14391074
Source Type: Journal
DOI: 10.1055/s-0029-1215550 Document Type: Review |
|
Times cited : (6)
|
|
References (2)
|
